Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vanaclocha

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Actas Dermo-Sifiliograficas|July 30, 2013
Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and VenereologyG Carretero, M Ribera, I Belinchón, et al.
Actas Dermo-Sifiliograficas|May 22, 2009
[Update of the topical treatment of psoriasis]J M Carrascosa, F Vanaclocha, L Borrego, et al.
The British Journal of Dermatology|April 30, 2004
Ciclosporin in psoriasis clinical practice: an international consensus statementC E M Griffiths, L Dubertret, C N Ellis, et al.
Actas Dermo-Sifiliograficas|March 8, 2011
[BIOBADADERM, the Spanish Registry of Adverse Events Associated with Biologic Drugs in Dermatology: first report]R Rivera, I García-Doval, G Carretero, et al.
The Pharmacogenomics Journal|November 19, 2014
Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasisA Julià, C Ferrándiz, E Dauden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 9, 2012
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registryA I Sánchez-Moya, I García-Doval, G Carretero, et al.
Actas Dermo-Sifiliograficas|July 16, 2017
Guidelines on the Use of Methotrexate in PsoriasisG Carretero, L Puig, L Dehesa, et al.
Actas Dermo-Sifiliograficas|September 23, 2010
[Guidelines on the use of methotrexate in psoriasis]G Carretero, L Puig, L Dehesa, et al.
Actas Dermo-Sifiliograficas|July 5, 2015
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over timeJ M Carrascosa, N Rivera, I Garcia-Doval, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 5, 2014
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registryC Medina, G Carretero, C Ferrandiz, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Actas Dermo-Sifiliograficas|July 30, 2013
Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and VenereologyG Carretero, M Ribera, I Belinchón, et al.
Actas Dermo-Sifiliograficas|May 22, 2009
[Update of the topical treatment of psoriasis]J M Carrascosa, F Vanaclocha, L Borrego, et al.
The British Journal of Dermatology|April 30, 2004
Ciclosporin in psoriasis clinical practice: an international consensus statementC E M Griffiths, L Dubertret, C N Ellis, et al.
Actas Dermo-Sifiliograficas|March 8, 2011
[BIOBADADERM, the Spanish Registry of Adverse Events Associated with Biologic Drugs in Dermatology: first report]R Rivera, I García-Doval, G Carretero, et al.
The Pharmacogenomics Journal|November 19, 2014
Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasisA Julià, C Ferrándiz, E Dauden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 9, 2012
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registryA I Sánchez-Moya, I García-Doval, G Carretero, et al.
Actas Dermo-Sifiliograficas|July 16, 2017
Guidelines on the Use of Methotrexate in PsoriasisG Carretero, L Puig, L Dehesa, et al.
Actas Dermo-Sifiliograficas|September 23, 2010
[Guidelines on the use of methotrexate in psoriasis]G Carretero, L Puig, L Dehesa, et al.
Actas Dermo-Sifiliograficas|July 5, 2015
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over timeJ M Carrascosa, N Rivera, I Garcia-Doval, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 5, 2014
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registryC Medina, G Carretero, C Ferrandiz, et al.
Pageof 11